HAI
AMRX icon

Hennessy Advisors Inc’s Amneal Pharmaceuticals AMRX Stock Holding History

Hennessy Advisors Inc’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,499,400
Closed -$12.6M – 344
2025
Q1 		$12.6M Sell
1,499,400
-171,200
-10% -$1.43M 0.42% 60
2024
Q4 		$13.2M Buy
1,670,600
+106,600
+7% +$894K 0.39% 58
2024
Q3 		$13M Buy
1,564,000
+175,400
+13% +$1.37M 0.42% 56
2024
Q2 		$8.82M Buy
+1,388,600
New +$8.82M 0.33% 75

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hennessy Advisors Inc's AMRX Position: Q2 2025 in Review

Hennessy Advisors Inc sold out of Amneal Pharmaceuticals (AMRX) in Q2 2025, closing a stake of 1,499,400 shares — an estimated $12.6M sold.

Hennessy Advisors Inc first reported a position in AMRX in Q2 2024 and held it in 4 quarters. The position peaked at $13.2M in Q4 2024. 241 funds tracked by Wall St. Rank hold AMRX as of Q2 2025.

  • Hennessy Advisors Inc reported no remaining Amneal Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Hennessy Advisors Inc sold 1,499,400 Amneal Pharmaceuticals shares in Q2 2025, an estimated $12.6M.
  • Hennessy Advisors Inc first reported a position in Amneal Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Hennessy Advisors Inc's Amneal Pharmaceuticals position peaked at $13.2M in Q4 2024.
  • 241 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2025.

Based on Hennessy Advisors Inc's 13F filing for Q2 2025, filed 21 Jul 2025.